Trial · NCT01838681
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period A | STARTED | Period A Placebo and ADT (8 Weeks) | 1,986 | |
| Period A | STARTED | Period B Placebo and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | STARTED | Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | STARTED | Period A+ Placebo and ADT (Non-randomised Patients) | 0 | |
| Period A | COMPLETED | Period A Placebo and ADT (8 Weeks) | 1,661 | |
| Period A | COMPLETED | Period B Placebo and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | COMPLETED | Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | COMPLETED | Period A+ Placebo and ADT (Non-randomised Patients) | 0 | |
| Period A | NOT COMPLETED | Period A Placebo and ADT (8 Weeks) | 325 | |
| Period A | NOT COMPLETED | Period B Placebo and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | NOT COMPLETED | Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment) | 0 | |
| Period A | NOT COMPLETED | Period A+ Placebo and ADT (Non-randomised Patients) | 0 | |
| Period B/A+ | STARTED | Period A Placebo and ADT (8 Weeks) | 0 | |
| Period B/A+ | STARTED | Period B Placebo and ADT (24 Weeks Randomised Treatment) | 442 | |
| Period B/A+ | STARTED | Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment) | 444 | |
| Period B/A+ | STARTED | Period A+ Placebo and ADT (Non-randomised Patients) | 770 | |
| Period B/A+ | COMPLETED | Period A Placebo and ADT (8 Weeks) | 0 | |
| Period B/A+ | COMPLETED | Period B Placebo and ADT (24 Weeks Randomised Treatment) | 380 | |
| Period B/A+ | COMPLETED | Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment) | 349 | |
| Period B/A+ | COMPLETED | Period A+ Placebo and ADT (Non-randomised Patients) | 653 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01838681/flow